Monograph Details
|
|
Gastrointestinal Tract
> Colorectal disorders
|
|
COLAZAL |
| Manufacturer |
|
Salix Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Salicylate. |
| Generic Name |
|
Balsalazide disodium (prodrug of mesalamine) 750mg; caps. |
| Indications |
|
Mildly to moderately active ulcerative colitis. |
| Children |
|
May swallow whole or sprinkle capsule contents into applesauce.<5yrs: not recommended. ≥5yrs: 2.25g 3 times daily or 750mg 3 times daily; max 8 weeks. |
| Adults |
|
May swallow whole or sprinkle capsule contents into applesauce. 2.25g 3 times daily for 8 weeks; max 12 weeks. |
| Precautions |
|
Pyloric stenosis. Renal dysfunction. History of renal disease. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
Headache, GI upset/pain, arthralgia, respiratory infection, insomnia, fatigue, anorexia, exacerbation of symptoms, pyrexia. |
| How Supplied |
|
Caps—280, 500 |
|
|
|
|
